Episodios

  • Navigating the Impact of Preservatives in Ophthalmic Medications: Insights From Dr. Robert J. Noecker

    Navigating the Impact of Preservatives in Ophthalmic Medications: Insights From Dr. Robert J. Noecker
    Jun 7 2024
    In this episode, Robert J. Noecker, MD, reviews the role of preservatives, particularly benzalkonium chloride (BAK), in ophthalmic medications. While BAK effectively prevents bacterial growth, its inherent toxicity poses challenges with prolonged use, leading to symptoms associated with ocular surface diseases. Dr. Noecker emphasizes the importance of exploring alternatives like preservative-free formulations or less toxic oxidizing preservatives, which should ensure effective glaucoma treatment without compromising ocular health. This activity is supported by an independent medical education grant from Théa Pharma.
    Más Menos
    14 m
  • Enhancing Patient Satisfaction through BAK-Free Solutions: Dr. Miriam Kolko's Vision for Preservative-Free Eye Care

    Enhancing Patient Satisfaction through BAK-Free Solutions: Dr. Miriam Kolko's Vision for Preservative-Free Eye Care
    Jun 6 2024
    In this episode, Miriam Kolko, MD, PhD, shares her vision for preservative-free eye care. Dr. Kolko strongly advocates for patient education regarding the benefits and limitations of preservative-free alternatives, encouraging tailored treatment strategies. Ultimately, she envisions a future where BAK-free alternatives take precedence in eye care, promoting better patient outcomes and adherence to treatment regimens. This activity is supported by an independent medical education grant from Théa Pharma.
    Más Menos
    12 m
  • Unveiling the Paradox: BAK's Role in American Pharmaceuticals With Dr. Nate Radcliffe

    Unveiling the Paradox: BAK's Role in American Pharmaceuticals With Dr. Nate Radcliffe
    Jun 5 2024
    In this episode, Nathan Radcliffe, MD, discusses the widespread use of benzalkonium chloride (BAK) in the US ophthalmic market. Dr. Radcliffe acknowledges concerns about its long-term effects, such as exacerbating dry eye and impacting the success of incisional glaucoma surgery. Preservative-free formulations are favored in Europe, and Dr. Radcliffe highlights the growing recognition among US eye care clinicians regarding the need for BAK alternatives. This activity is supported by an independent medical education grant from Théa Pharma.
    Más Menos
    11 m
  • The European Approach to Preservative-Free Pharmaceuticals: A Conversation With Dr. Anton Hommer

    The European Approach to Preservative-Free Pharmaceuticals: A Conversation With Dr. Anton Hommer
    Jun 4 2024
    In this episode, Anton Hommer, MD, discusses the European perspective on adopting preservative-free pharmaceuticals, highlighting challenges like health care professionals’ reluctancy to change, diverse reimbursement systems, and higher costs. He compares single-use and multiuse drugs, considering factors such as environmental impact and cost-effectiveness. Dr. Hommer emphasizes the superior efficacy of preservative-free medications, especially in treating chronic conditions such as glaucoma, and anticipates an increase in their use to protect ocular health and enhance chronic disease management. This activity is supported by an independent medical education grant from Théa Pharma.
    Más Menos
    12 m
  • Optics and Aberrations

    Optics and Aberrations
    Mar 15 2024
    Zaina Al-Mohtaseb, MD, and Douglas D. Koch, MD, delve into the realm of optics and aberrations. They cover a range of topics, including spherical and chromatic aberrations, ABBE numbers, and residual refractive error. Additionally, they explore various intraocular lens (IOL) designs, emphasizing the impact of these designs and manufacturing processes on visual quality. This activity is supported by independent medical education grants from Alcon, Johnson & Johnson Vision, and STAAR Surgical.
    Más Menos
    15 m
  • Lens Lights Filters

    Lens Lights Filters
    Mar 14 2024
    Zaina Al-Mohtaseb, MD, and Douglas D. Koch, MD, delve into the potential benefits and drawbacks of incorporating light filters into lens designs, focusing specifically on blue and violet filters. As they explain the science behind these filters, Drs. Al-Mohtaseb and Koch discuss how they are revolutionizing our understanding of intraocular lenses (IOLs) and influencing the overall visual experience for patients, moving beyond theoretical considerations to practical implications. This activity is supported by independent medical education grants from Alcon, Johnson & Johnson Vision, and STAAR Surgical.
    Más Menos
    9 m
  • Reducing Posterior Capsule Opacification

    Reducing Posterior Capsule Opacification
    Mar 13 2024
    Cathy McCabe, MD, and Karl Stonecipher, MD, discuss how factors such as lens design, material, and haptics influence the selection of intraocular lenses (IOLs) and affect patients’ long-term visual outcomes. They also delve into the management of posterior capsule opacification (PCO), emphasizing the importance of achieving patient satisfaction. This activity is supported by independent medical education grants from Alcon, Johnson & Johnson Vision, and STAAR Surgical.
    Más Menos
    14 m
  • Innovations in Lens Technology and Visual Quality

    Innovations in Lens Technology and Visual Quality
    Mar 12 2024
    Cathy McCabe, MD, and Karl Stonecipher, MD, delve into the intricacies of different lens designs, discussing how they impact both patient outcomes and surgeon experience. The conversation also explores the significance of patient education and emphasizes the value of making well-informed decisions based on factors such as corneal health and refractive history. Looking ahead, Drs. McCabe and Stonecipher shed light on forthcoming innovations while conveying their expectations for future developments in lens technologies. This activity is supported by independent medical education grants from Alcon, Johnson & Johnson Vision, and STAAR Surgical.
    Más Menos
    16 m